(23739912), D. E., (23739915), O. T., (22928644), M. E., (23739918), A. K., (23739921), L. A., (23739924), A. A., . . . (112613), L. D. (2025). Ivabradine, a hyperpolarization-activated channel blocker, attenuates mechanical, but not heat, hypersensitivity in hyperglycaemic and normoglycemic rat models of diabetic neuropathy.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(23739912), Dina Elsayegh, Omar Tluli (23739915), Maram Elzayyat (22928644), Abdelrahman Karen (23739918), Layan Albarghouthi (23739921), Abdulla Al-Emadi (23739924), Mubarak AlMaadid (23739927), Haya Al-Mohannadi (20362818), و Laiche Djouhri (112613). Ivabradine, a Hyperpolarization-activated Channel Blocker, Attenuates Mechanical, but Not Heat, Hypersensitivity in Hyperglycaemic and Normoglycemic Rat Models of Diabetic Neuropathy. 2025.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(23739912), Dina Elsayegh, et al. Ivabradine, a Hyperpolarization-activated Channel Blocker, Attenuates Mechanical, but Not Heat, Hypersensitivity in Hyperglycaemic and Normoglycemic Rat Models of Diabetic Neuropathy. 2025.